Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-11-035590
Filing Date
2011-02-14
Accepted
2011-02-14 18:19:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G dsc13g.htm SC 13G 56665
  Complete submission text file 0001193125-11-035590.txt   58348
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Subject) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-85205 | Film No.: 11608823
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 99 SUMMER STREET BOSTON MA 02110
FRONTIER CAPITAL MANAGEMENT CO LLC (Filed by) CIK: 0001216488 (see all company filings)

EIN.: 043492668 | State of Incorp.: DE
Type: SC 13G